La duloxetine (Cymbalta)

[en] Duloxetine (Cymbalta is an antidepressant of the class of serotonin noradrenaline reuptake inhibitors. The efficacy of duloxetine 60 mg/day has been well demonstrated in the acute and long term treatment of major depression. The level of effectiveness of duloxetine is particularly high and associated with a shorter latency of action. Duloxetine also exhibits antinociceptive properties independently of the antidepressant effect. The side-effect profile of duloxetine is particularly good and similar to selective serotonin reuptake inhibitors with mainly nausea. In total, duloxetine represents a real progress in the pharmacological treatment of major depression.

Disciplines :

Psychiatry

Author, co-author :

Pitchot, William ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale

Language :

French

Title :

La duloxetine (Cymbalta)

Alternative titles :

[en] Medication of the Month. Duloxetine (Cymbalta)

Publication date :

November 2006

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

787-90

Peer reviewed :

Peer reviewed

Available on ORBi :

since 10 July 2014

Statistics

Number of views

256 (0 by ULiège)

Number of downloads

566 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Angst J. - Epidemiology of depression. In Depression : Neurobiological, Psychopathological and Therapeutic Advances, Honig A. and van Praag H.M. (Eds.), John Wiley & Sons Ltd, 1997, 17-27.
Hirschfeld R.M.A. - Guidelines for long-term treatment of depression. J Clinical Psychiatry, 1994,.55, 61-69.
Bostwick JM, Pankratz VS. - Affective disorders and suicide risk : a reexamination. Am J Psychiatry, 2000, 157, 1925-1932.
Pitchot W, Dierick M, D'Haenen H. - Troubles affectifs. In Dierick M, Ansseau M, D'Haenen H, Peuskens J, Linkowski P. (Eds), Manuel de Psychopharmacothérapie, Gent, Academia Press, 2003,169-230.
Kirwin JL, Gören JL. - Duloxetine : a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy, 2005, 25, 396-410.
Bollen J, Constant E, Domken MA, et al. - Through a better and broader symptom control. Acta Psychiatrica Belgica , in press.
Detke MJ, Wiltse CG, Mallinckrodt CH, et al. - Duloxetine in the acute and long-term treatment of major depressive disorder : a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol, 2004, 14, 457-470.
Goldstein DJ, Lu Y, Detke MJ, et al. - Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics, 2004, 45, 17-28.
Thase M et al. - Remission rates in double-blind, placebo-controlled clinical trials of duloxetine with SSRI as a comparator. Eur Neuropsychopharmacol, 2003, 13, S214.
Raskin J, Goldstein DJ, Mallinckrodt CH, Ferguson MB. - Duloxetine in the long-term treatment of major depressive disorder. J Clin Psychiatry, 2003, 64, 1237-1244.
Fava M, Mallinckrodt CH, Detke MJ, et al. - The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates ? J Clin Psychiatry, 2004, 65, 521-530.
Mallinckrodt CH, Goldstein DJ, Detke MJ, et al. - Duloxetine : A new treatment for the emotional and physical symptoms of depression. Prim Care Companion J Clin Psychiatry, 2003, 5, 19-28.
Dunner DL, Goldstein DJ, Mallinckrodt CH, et al. - Duloxetine in treatment of anxiety symptoms associated with depression. Depress Anxiety, 2003, 18, 53-61
Brannan SK, Mallinckrodt CH, Brown EB, et al. - Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatric Res, 2005, 39, 43-53.
Raskin J, Pritchett YL, Wang F, et al. - A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Medicine, 2005, 6, 346-356.